Senstar Technologies Corporation — FY2023 Form 20-F
Reporting period: Year ended December 31, 2023. This is an annual report, not a standalone fourth-quarter filing. Financial statements are in U.S. dollars and prepared under U.S. GAAP. Senstar sells perimeter intrusion detection, video management and analytics, and access-control products and services to customers in more than 100 countries.
Financial performance
| Metric | FY2023 | FY2022 | Change / context |
|---|---|---|---|
| Revenue | $32.8 million | $35.6 million | Down 7.8%; management attributed the decline mainly to a one-time Asia project that boosted 2022 revenue. |
| Gross profit / margin | $18.8 million / 57% | $21.5 million / 60% | Margin declined, which the company attributed to sales mix and higher material costs. |
| Operating income (loss) | $(1.3) million | $1.5 million | Shifted to an operating loss as revenue fell and mix changed; selling and marketing expense also rose. |
| Net income (loss) | $(1.3) million | $3.8 million | FY2022 included a $2.4 million income tax benefit; FY2023 tax benefit was less than $0.1 million. |
| Operating cash flow | $0.3 million provided | $9.5 million used | FY2023 working-capital movements included lower inventory and receivables, partly offset by lower payables and higher prepaid/other receivables. |
| Cash, cash equivalents and restricted cash | $14.8 million | $14.9 million | Cash and short-term deposits were reported at $14.9 million at year-end 2023. |
Research and development expense was approximately $4.0 million, broadly flat year over year. Selling and marketing expense increased 10.5% to $10.0 million, while general and administrative expense fell 11.8% to $6.2 million. Services and maintenance accounted for 16.2% of revenue, versus 17.7% in 2022. Geographic revenue included $14.8 million from North America, $11.4 million from Europe, and $3.9 million from APAC.
Liquidity, debt and balance sheet
- At December 31, 2023, total assets were $50.3 million, total liabilities were approximately $13.1 million, and shareholders’ equity was $37.2 million.
- The filing describes credit facilities and bank guarantees rather than material funded borrowings. Credit lines totaled approximately $2.0 million in the financial-statement note, with $1.6 million utilized for performance, advance-payment and bid guarantees. Separately, management described lines of $1.5 million at two Israeli banks, with less than $0.1 million available, and a $0.6 million Canadian line, with $0.4 million available. These disclosures should be reconciled; guarantees are not the same as drawn debt.
- Capital spending was $0.4 million in 2023. Management estimated approximately $0.4 million of capital expenditures for 2024 and said it expected to fund these mainly from cash and operating cash flow.
Material changes, outlook and risks
- Senstar reported a return to loss after profits in 2022 and 2021. Revenue has also been affected by lingering regional impacts from COVID-19 and supply-chain constraints; management said it sourced materials needed to continue deliveries, but warned that shortages, supplier dependence and higher input costs could recur.
- Management expects 2024 research and development expense of approximately $4.3 million. The filing provides no specific revenue or earnings guidance. Remaining performance obligations were $3.5 million at year-end; approximately 47% was expected to be recognized as revenue in 2024.
- Business risks include lengthy government procurement cycles and customer budget exposure, seasonal revenue concentration toward year-end, intense competition, foreign-exchange movements, international operating risks, and reliance on a limited supplier base. No assurance of future profitability is provided.
- Goodwill was $11.1 million. The company’s fourth-quarter discounted-cash-flow impairment test found no impairment, but the auditor identified goodwill impairment assessment as a critical audit matter because estimates of growth, margins and the discount rate involve uncertainty.
- The company disclosed $1.1 million of uncertain tax positions at year-end. A former subsidiary’s Mexican tax dispute resulted in a 2022 agreement for Senstar to reimburse the buyer $4.25 million; investors should confirm the payment and any remaining obligations from the relevant notes and subsequent disclosures. Royalty obligations of approximately $0.6 million to Israel’s Innovation Authority are contingent on future sales of specified grant-funded products.
- Senstar completed its redomiciliation from Israel to Ontario on March 18, 2024, after the fiscal year-end. Shares continued to trade on Nasdaq under SNT, and the share count remained 23,309,987. The filing says the expected benefits of the redomiciliation are not assured.
- FIMI partnerships collectively held approximately 42.3% of shares as of April 17, 2024, giving them significant influence. The company reported effective management disclosure controls and effective internal control over financial reporting as of December 31, 2023; the auditor did not express an opinion on internal controls.
Most important facts for investors to verify
- Whether the 2023 operating loss and lower gross margin are temporary or reflect sustained cost, mix or demand pressure.
- Whether cash generation improves and how much of reported liquidity is restricted, committed to guarantees, or held above insured bank limits.
- The precise status and accounting treatment of the $4.25 million Mexican tax reimbursement and any related outstanding exposure.
- Whether management’s 2024 R&D and capital-expenditure estimates, and expected recognition of remaining performance obligations, are tracking to plan.
- Goodwill-test sensitivity to forecast growth, margins and discount rates, given goodwill of $11.1 million and the auditor’s critical audit matter.
- The practical effects of the Ontario redomiciliation, including tax, governance and shareholder-rights implications, and FIMI’s continuing control influence.